A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.


Updates from The Motley Fool

Latest updates on PDL BioPharma from Fool.com.


Stock Performance

PDLI vs. S&P 500 | 2 Year Performance
View Interactive PDLI Charts
Sponsored by

Key Data Points

Primary metrics and data points about PDL BioPharma.
Current Price: $2.86
Prev Close: $2.87
Open: $2.85
Bid: $2.82
Ask: $2.88
Day's Range: $2.83 - $2.90
52wk Range: $2.58 - $5.68
Volume: 757,882
Avg Vol 1,416,191
Market Cap: $467.83M
P/E (ttm): 2.01
EPS (ttm): $1.43
Div & Yield: $0.60 (7.0%)

Company Rating

What our community thinks about PDL BioPharma.
CAPS Rating 3 out of 5
 
842 Outperform
48 Underperform
CAPS All Stars
 
169 Outperform
12 Underperform

How do you think PDL BioPharma will perform against the market?



You pick for PDL BioPharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John P. McLaughlin, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for PDL BioPharma.

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers